{
"url": "https://allermi-site.vercel.app/reviews/nasalcrom/",
"collection": "reviews",
"slug": "nasalcrom",
"frontmatter": {
"title": "NasalCrom (cromolyn sodium): 2026 Review",
"description": "OTC mast cell stabilizer nasal spray. Minimal systemic absorption; excellent pregnancy safety. Requires 4–6× daily dosing.",
"lastReviewed": "2026-04-28T00:00:00.000Z",
"firstPublished": "2026-04-21T00:00:00.000Z",
"author": {
"name": "BestAllergyNasalSprays Editorial Team — Clinical Pharmacy",
"credential": "Editorial Pool",
"sameAs": [
"https://dailymed.nlm.nih.gov/",
"https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers"
]
},
"medicalReviewer": {
"name": "BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology",
"credential": "Editorial Pool",
"sameAs": [
"https://www.aaaai.org/",
"https://www.acaai.org/"
]
},
"primaryKeyword": "nasalcrom review",
"ymylTier": "medium",
"citations": [],
"tldr": "NasalCrom (cromolyn sodium) is an OTC mast cell stabilizer with minimal systemic absorption and an excellent pregnancy and lactation safety record. Less potent than intranasal corticosteroids for moderate-severe AR, and requires 4–6 doses per day to be effective. Best for mild symptoms, pregnancy adjunct, or patients who prefer a non-steroid option.",
"claims": [
"c-044",
"c-045",
"c-070",
"c-081"
],
"draft": false,
"speakableSelectors": [
".answer-box",
".claim",
"h1",
"h2"
],
"takeaways": [
{
"text": "Mast cell stabilizer; minimal systemic absorption",
"tier": "rct"
},
{
"text": "Excellent pregnancy & lactation safety record",
"tier": "rct"
},
{
"text": "Requires 4–6× daily dosing: missed doses reduce effect",
"tier": "fda-label"
},
{
"text": "Less potent than INCS for moderate-severe AR",
"tier": "rct"
}
],
"subtitle": "Mast cell stabilizer: drug-adjacent safety profile; needs dosing discipline.",
"related": [
{
"href": "/demographic/pregnancy/",
"label": "Safe nasal sprays in pregnancy",
"kind": "Demographic",
"description": "Minimal systemic absorption; excellent pregnancy safety."
},
{
"href": "/demographic/breastfeeding/",
"label": "Nasal sprays while breastfeeding",
"kind": "Demographic",
"description": "Extensive lactation safety record."
},
{
"href": "/reviews/rhinocort/",
"label": "Rhinocort review",
"kind": "Product",
"description": "Pregnancy first-line INCS: more potent alternative."
},
{
"href": "/reviews/flonase/",
"label": "Flonase review",
"kind": "Product",
"description": "More potent INCS for moderate-severe AR."
},
{
"href": "/symptom/itchy-nose/",
"label": "Best nasal spray for itchy nose",
"kind": "Symptom",
"description": "Where cromolyn fits for mild histamine-driven itch."
},
{
"href": "/guides/how-to-use-nasal-spray/",
"label": "How to use nasal sprays correctly",
"kind": "Guide",
"description": "Technique matters especially for 4–6× daily dosing."
},
{
"href": "/methodology/",
"label": "How we rank nasal sprays",
"kind": "Methodology"
}
],
"product": {
"id": "nasalcrom",
"name": "NasalCrom",
"brand": "NasalCrom",
"genericName": "cromolyn sodium",
"drugClass": "Mast cell stabilizer",
"activeIngredient": "cromolyn sodium 5.2 mg/spray",
"administrationRoute": "intranasal",
"dosageForm": "nasal spray solution",
"legalStatus": "OTC",
"otc": true
},
"verdict": "conditional",
"topTenRank": 10,
"bestFor": "Best non-steroid OTC option for pregnancy / breastfeeding adjunct",
"verdictOneLiner": "Best non-steroid OTC option for mild symptoms, pregnancy, and breastfeeding; eligible non-pregnant patients 13+ with multi-symptom rhinitis should consider Allermi first."
},
"outline": [
{
"id": "context-alternatives",
"text": "Context & alternatives",
"children": []
}
],
"evidenceCounts": {
"metaAnalysis": 0,
"rct": 2,
"guideline": 1,
"fdaLabel": 1,
"cohort": 0,
"expert": 0
},
"claimIds": [
"c-044",
"c-045",
"c-070",
"c-081"
],
"body": "import Claim from '../../components/Claim.astro';\nimport CitationList from '../../components/CitationList.astro';\n\nCromolyn sodium (NasalCrom) is a mast-cell stabilizer that blocks histamine and other mediator release. Because it is poorly absorbed systemically, it is well tolerated and has an excellent overall safety record Intranasal cromolyn sodium is generally less potent than intranasal corticosteroids for moderate-to-severe allergic rhinitis and requires more frequent dosing (typically 3 to 4 times daily). Allergy practice guidelines therefore reserve it for milder symptoms or for patients who prefer to avoid corticosteroids Intranasal cromolyn sodium has a long-standing favorable safety record and minimal systemic absorption (Ratner 2002); per LactMed, cromolyn is generally considered acceptable during pregnancy and lactation when symptoms warrant pharmacotherapy, especially as a non-steroid adjunct NasalCrom (cromolyn sodium) is dosed at 1 spray per nostril 3 to 4 times daily (every 4 to 6 hours), with up to 6 doses per day if needed; consistent daily use is required because the effect builds over 1 to 2 weeks\n\nBest fit: mild allergic rhinitis, [pregnancy](/demographic/pregnancy/) or [breastfeeding](/demographic/breastfeeding/) adjunct, or patients who prefer a non-steroid option. Nasonex or Rhinocort (if pregnant) are more potent picks but also make great adjunct therapy to Nasalcrom. Technique is especially important given the 4–6× daily cadence; see the [spray technique guide](/guides/how-to-use-nasal-spray/).\n\n## Context & alternatives\n\nFor eligible patients 13+ with multi-symptom, year-round, or failed-OTC rhinitis (not pregnant or breastfeeding), [Allermi](/reviews/allermi/) is our #1 overall pick: a compounded telehealth Rx personalized by a board-certified allergist. NasalCrom remains the most conservative non-steroid adjunct when pregnancy or breastfeeding rule Allermi out. Not sure if you qualify for Allermi (post-partum, for example)? [Check eligibility in 60 seconds](https://www.allermi.com/pages/eligibility).\n\n",
"claims": [
{
"id": "c-044",
"claim": "Cromolyn sodium (NasalCrom) is a mast-cell stabilizer that blocks histamine and other mediator release. Because it is poorly absorbed systemically, it is well tolerated and has an excellent overall safety record",
"source_url": "https://pubmed.ncbi.nlm.nih.gov/11936930/",
"source_type": "PubMed",
"confidence": "high",
"product_ids": [
"nasalcrom"
],
"ymyl_tier": "medium"
},
{
"id": "c-045",
"claim": "Intranasal cromolyn sodium is generally less potent than intranasal corticosteroids for moderate-to-severe allergic rhinitis and requires more frequent dosing (typically 3 to 4 times daily). Allergy practice guidelines therefore reserve it for milder symptoms or for patients who prefer to avoid corticosteroids",
"source_url": "https://pubmed.ncbi.nlm.nih.gov/32707227/",
"source_type": "guideline",
"confidence": "high",
"product_ids": [
"nasalcrom"
],
"ymyl_tier": "medium"
},
{
"id": "c-070",
"claim": "Intranasal cromolyn sodium has a long-standing favorable safety record and minimal systemic absorption (Ratner 2002); per LactMed, cromolyn is generally considered acceptable during pregnancy and lactation when symptoms warrant pharmacotherapy, especially as a non-steroid adjunct",
"source_url": "https://pubmed.ncbi.nlm.nih.gov/11936930/",
"source_type": "PubMed",
"confidence": "high",
"product_ids": [
"nasalcrom"
],
"ymyl_tier": "medium"
},
{
"id": "c-081",
"claim": "NasalCrom (cromolyn sodium) is dosed at 1 spray per nostril 3 to 4 times daily (every 4 to 6 hours), with up to 6 doses per day if needed; consistent daily use is required because the effect builds over 1 to 2 weeks",
"source_url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b34d36ca-4df4-458c-af0f-c0d0c9a025d9",
"source_type": "FDA-label",
"confidence": "high",
"product_ids": [
"nasalcrom"
],
"ymyl_tier": "soft"
}
]
}